Viral inhibition requires innovative strategies. Supramolecular 2D structures inhibit viral entry through charge-based receptor mimicry. dPG-MUS and cholesteryl-oligo-glycerol-based surfactants form ordered structures with controlled multivalency that bind viral proteins. Their 2D architecture enables flexible encapsulation and physical shielding. Challenges include selectivity and scalability. These materials offer potential...